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Abstract
Background
Mongolia is one of the endemic countries for cystic echinococcosis (CE), a zoonotic disease
caused by the larval stage of Echinococcus granulosus. The goal of this study is to describe
the current clinical management of CE in Mongolia, to capture the distribution of cyst stages
of patients treated, and to contrast current practice with WHO-IWGE expert consensus.
Methods
Hospital records of CE patients treated between 2008 and 2015 at the three state hospitals
and fulfilling the inclusion criterion ‘discharge diagnosis CE’ (ICD 10 code B.67.0–67.9)
were reviewed. Demographical, geographical, clinical and ultrasonography (US) data were
extracted and analyzed. The annual surgical incidence was estimated. The digital copies of
US cyst images were independently staged by three international experts following the
WHO CE cyst classification to determine the proportions of patients which ideally would
have been assigned to the WHO recommended treatment modalities surgery, percutane-
ous, medical (benzimidazole) treatment and watch & wait.
Results
A total of 290 patient records fulfilled the inclusion criteria of the study. 45.7% of patients
were below 15 years of age. 73.6% of CE cysts were located in abdominal organs, predomi-
nately liver. US images of 84 patients were staged and assessed for inter-rater agreement.
The average raw agreement was 77.2%. Unweighted Kappa coefficient and weighted
Kappa was 0.57 and 0.59, respectively. Mean proportions of images judged as stages CE1,
CE2, CE3a, CE3b, CE4 and CL were 0.59, 0.01, 0.19, 0.08, 0.03 and 0.11, respectively.
40 cysts met the inclusion criteria of treatment modality analysis. The mean proportions of
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cases with a single cyst assigned to medical, percutaneous treatment, surgery and watch &
wait were 52.5% (95% CI 42–65), 25.8% (95% CI 15–30), 5.1% (95% CI 0–10) and 3.3%
(95% CI 0.0–10), respectively. 13.3% (95% CI 5–25) of cysts were staged as CL and there-
fore assigned to further diagnostic requirement.
Conclusion
WHO CE cyst classification and WHO-IWGE expert consensus on clinical CE management
is not implemented in Mongolia. This results in exclusively surgical treatment, an unneces-
sary high risk approach for the majority of patients who could receive medical, percutaneous
treatment or observation (watch & wait). Introduction of WHO-IWGE expert consensus and
training in ultrasound CE cyst staging would be highly beneficial for patients and the health
care services.
Author summary
Cystic Echinococcosis (CE) is a zoonotic disease, commonly known as dog tapeworm.
The disease is distributed globally and predominantly affects rural populations with lim-
ited access to health care. Following the expert consensus of the WHO-Informal Working
Group on Echinococcosis (WHO—IWGE) patients with uncomplicated cysts are assigned
on the basis of WHO cyst classification to four treatment modalities: medical (benzimid-
azoles), percutaneous, surgical treatment, and ‘watch & wait’. In Mongolia, one third of
the population practices nomadic farming. These populations are heavily affected by CE.
However, cyst staging and WHO-IWGE recommendations are not implemented and
patients referred to the three national treatment centres receive surgical treatment. This
exposes a large proportion of patients to an unnecessary high risk approach who could be
treated–depending on cyst stage—with benzimidazoles, percutaneously or observed
(watch & wait). We reviewed the hospital records of patients with CE and admitted
between 2008 and 2015 to the three national CE treatment centres, retrospectively staged
the cysts and assigned the patients to the four WHO-IWGE recommended treatment
modalities. We found a high proportion of patients in the study population who would
have most likely benefitted from non-surgical treatment options.
Introduction
Cystic echinococcosis (CE) is a zoonotic disease caused by the larval stage of Echinococcus
granulosus. The life cycle of E. granulosus is maintained between the dog as the definitive host
and various livestock as the intermediate host. Humans are considered as an aberrant interme-
diate host. Ingested larvae develop into cystic lesions, mostly in the liver and lung [1]. The dis-
ease is globally distributed including Central Asian countries and China [2–4]. The current
global burden of disease is estimated at 188,000 Disability Adjusted Life Years (DALYs) [5, 6].
Due to a large proportion of asymptomatic cases and underreporting the disease burden is
widely underestimated. Pastoral communities in countries with limited resources bear the
greatest burden [3, 5, 7].
In Mongolia, one-third of the population is engaged in extensive pastoral farming. The
presence of a large livestock population accompanied by watchdogs, a big number of stray
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dogs, unregulated private slaughtering, and lack of health education are the main reasons for
the heavy human CE exposure [8, 9]. Historically, due to strong public and veterinary action,
the surgical cases decreased from 13% in 1946 to 2% in 1988 in the state hospital [10, 11]. After
the Soviet Union collapsed in 1990, the veterinary and public health sectors weakened and
many control programs for zoonotic disease, including CE, collapsed [12]. Currently, CE is
not included in the national surveillance system, and official statistics are, therefore, unavail-
able [8, 9, 13]. There are few reports on the current transmission of CE in Mongolia by small
scale serological surveys, hampered, however, by the sensitivity and specificity problems of
serological CE testing [11, 14–18].
CE predominantly affects rural populations with very limited access to health care [19].
Diagnosis, cyst staging, treatment and follow-up depend on imaging [20, 21]. Ultrasonogra-
phy, however, is only recently introduced in low and lower middle income countries (LICs
and LMICs)[22–24]. Thus most endemic countries, including Mongolia, have not yet imple-
mented the WHO Informal Working Group (WHO-IWGE) expert consensus [25, 26]. The
core piece of the WHO-IWGE expert consensus is to triage on the basis of ultrasound-defined
cyst stages into four groups: medical, percutaneous, surgical treatment (active cyst stage CE1
to CE3b) and ‘watch & wait’ (inactive cyst stages CE4 and CE5) [20, 27–30].
The goal of this study is to describe the current clinical management of CE in Mongolia, to
capture the distribution of cyst stages retrospectively from stored ultrasound images, to criti-
cally contrast current practice in Mongolia with WHO-IWGE expert consensus and to suggest
a LIC / LMICs-adapted implementation strategy for WHO-IWGE expert consensus.
Materials and method
Ethics statement
This work presented here was approved by the Medical Ethics committee of Mongolia (July
2014) and WHO ERC (27 Nov 2015).
Study area and data collection
We reviewed the hospital records of patients diagnosed with CE and admitted between 2008
and 2015 to the three state hospitals conducting CE surgery in Mongolia: First Central Hospi-
tal (FCH), Third Central Hospital (TCH), National Center for Maternal and Child Health
(NCMCH). Patients identified as probable CE cases in the peripheral or secondary hospitals
are, as a rule, referred to the three state hospitals for confirmation and surgery. In the archives
of the state hospitals, the medical records are chronologically stored in bundles of 150–200
reports. On the front page of each record the discharge diagnosis is recorded by the surgeon,
based on histopathology which is done as a routine in the national hospitals. The ‘discharge
diagnosis CE’ (ICD 10 code B.67.0–67.9) was the inclusion criteria for our study.
The following data were extracted from the patient records on data extraction sheets: demo-
graphic and geographic data (specified in Table 1), clinical symptoms and signs, ultrasonogra-
phy (US) reports including number and size of cysts, US images, surgical reports and final
diagnosis. US images (photos) were digitalized and stored. The data collected on data extrac-
tion sheets were double entered into a data base.
Data analysis
The demographic information including age, sex, occupation, type of home, and distance
from health care was presented with the relevant percentage. The distance between secondary
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hospital (provincial general hospital) and current address of the patient was calculated. The
levels of the clinical care in Mongolia are provided in the (Fig A in S1 Appendix).
The socio-economic status (SES) in the adult patients was stratified according to the labour
force category of the National Statistical Office [31]. The current address of the patient was
used to plot the geographical distribution by employing the ArcGIS 10.0 (ESRI 2011. ArcGIS
Desktop: Release 10. Redlands, CA: Environmental Systems Research Institute). The annual
surgical incidence was estimated based on the hospital records. The frequency of the clinical
signs & symptoms was calculated. The size and number of CE cysts were presented in three
different categories, <5 cm, 5–10 cm, and >10 cm and single cyst, 1–3 cysts, and multiple
cysts, respectively.
The digital copies of US cyst images were independently reviewed by three international
experts (reviewers) to estimate the frequency distribution of cyst stages according to WHO
cyst classification (CL, CE1, CE2, CE3a, CE3b, CE4, CE5) in the patient population referred to
the state hospitals for confirmatory assessment and treatment. The exercise was performed on
the US images of abdominal lesions. The experts received no further information about the
patients. Duplicate images of cysts were provided when available. If the reviewer felt unable to
Table 1. Demography, socio-economic status (SES) and geographical data of the patients.
Patient characteristics Frequency
n %
Age
0–14 113 45.7
15–59 116 47.0
>60 18 7.3
Total 247 100
Sex
Male 116 47.0
Female 131 53.0
Total 247 100
Occupation
Paid employee 42 34.4
Self-employed 16 13.1
Employed in animal husbandry 12 9.8
Unemployed/retired/disabled 52 42.6
Total 122 100
Distance from secondary level hospital
<100 km 107 62.2
100 km-200 km 53 30.8
>200 km 12 6.9
Total 172 100
Type of home
Apartment 47 19.0
Yurt 200 81.0
Total 247 100
- 60 pediatric cases and 65 cases without information on employment were excluded from calculating the
percentage of occupation.
- 60 cases from Ulaanbaatar city and 15 cases without an exact address were excluded from calculating the
percentage of distance
https://doi.org/10.1371/journal.pntd.0006686.t001
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stage a cyst, e.g. because of poor quality of an image, the cyst was classified ‘not identifiable’
(NI). After the assessment, exclusions were made on the double images. If a double image of a
cyst was assessed identical by the reviewers, we selected randomly one of the images. If a dou-
ble images was assessed not identical by the reviewers, the one with fewer “NI” votes was
selected to represent the cyst. Inter-rater agreement was calculated using the Kappa statistic.
Raw agreement was calculated as the proportion of cysts where the raters noted the same stage
and kappa statistics for ordered categories (CL, CE1, CE2, CE3a, CE3b, CE4, CE5). We report
both, unweighted and weighted kappa statistics with weights calculated as the square of the
distance between the two ordinal groups. We judged agreement as poor if κ< 0.2; fair if 0.2
κ< 0.4; moderate if 0.4 κ< 0.6; substantial if 0.6 κ< 0.8; and good if κ> = 0.8. The esti-
mates represent the arithmetic mean of the 3 pair-wise comparisons. “NI” judgements were
considered as missing values which have been excluded pair-wise for raw agreement and
kappa estimation.
Allocation of the cysts to WHO recommended treatment modalities was performed on the
basis of cyst staging by the 3 reviewers and cyst size. Cases in whom images were assessed as
“NI” by all three reviewers were excluded; equally, cases with more than one cyst since com-
pleteness and ascertainment of US images was difficult retrospectively. The double images
were excluded using the same algorithm as in the analysis of interrater-agreement. We calcu-
lated combinations of CE stage and cyst size for all three reviewer assessments separately and
calculated the mean percentage. Based on this combination, the probability of assignment of
cases to the treatment modalities as defined by the WHO-IWGE expert consensus were esti-
mated for each case. Assignment of cysts to WHO recommended treatment modalities was
performed as if all cysts were uncomplicated since the retrospective data did not allow to reli-
ably differentiate complicated from uncomplicated cyst. Bootstrap resampling with 10,000 rep-
licates was used for estimating the 95% confidence intervals for the treatment options. The
analysis was conducted using the statistical package R v 3.4.0.
Results
A total of 290 medical records fulfilled the inclusion criterion ‘discharge diagnosis CE’ (ICD
10 code B.67.0–67.9) of the patients admitted to the three state hospitals between 2008 and
2015, 43 records were excluded. For details see Fig 1.
The demographic data are presented in Table 1.
During the period 2008–2015, the average CE surgical incidence per 100 000 was 1.06 (95%
CI 0.7–1.4) based on the current data collection. On average 30.8 (95% CI 20.4–41.3) cases per
annum underwent CE surgery in the central hospitals between 2008 and 2015 (Fig B in S1
Appendix).
The patients originated from 20 provinces corresponding to 95% (20/21) of all provinces
(Fig 2). The southern provinces Omnogobi (OG), Dundgobi (DU), and Bayankhongor (BH)
have the highest number of cases. Average CE surgical incidence for the survey period in these
provinces was 2.7–6.1 per 100 000 inhabitants based on the medical records in the three central
hospitals.
The frequency of symptoms & signs in CE patients at admission to the three state hospitals
are provided in Fig C in S1 Appendix. The location of CE cysts of the surgically treated patients
at the three state hospitals between 2008 and 2015 are provided in Fig D in S1 Appendix.
Preoperative ultrasound reports were available in 83.5% (152/182) of patients who had
undergone abdominal surgery for CE. 21.9% (40/182) were explicitly recorded as hydatid
cysts, 45% (83/182) as cystic lesions, and 15.9% (29/182) as other space occupying lesions. 83%
(151/182) of the abdominal cases had the information on the cyst number in the US record.
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Among them, 78.1% (118/151) had single cyst, 20% (31/151) have 1–3 cysts and 1.3% (2/151)
have more than 3 cysts. The information on size were available for 75.2% (137/182) of the
abdominal cases. Among them, 48.9% (67/137) had cysts smaller than 5 cm, 35.0% (48/137) of
5–10 cm and 16.1% (22/137) were bigger than 10 cm.
138 US imaging photos of 84 cases with liver and abdominal cysts were available for review
and CE cyst staging based on the WHO CE cyst classification by three international reviewers.
Following the inclusion / exclusion procedures described in the method section images of 84
unique cysts were assessed for inter-rater agreement analysis. The raw agreement was 77.2%.
We observed substantial agreement with an average unweighted Kappa coefficient of 0.57 and
an average weighted Kappa coefficient of 0.59 (squared weights). The proportions of CE cyst
stages are shown in Fig 3. Mean proportion for CE stages including CE1, CE2, CE3a, CE3b,
CE4, and CL were 0.59, 0.01, 0.19, 0.08, 0.03 and 0.11, respectively. No CE5 cysts were
identified.
Of the cysts staged by the three reviewers, 40 met the inclusion criteria for the treatment
modality analysis (selection process see methodology section). The mean proportion of cases
assigned to albendazole, percutaneous treatment, surgery and watch & wait was calculated as
Fig 1. Selection of CE surgical case records. (a) 290 records (patients) in the 3 central hospitals in Mongolia fulfilled
the inclusion criterion ‘discharge diagnosis CE’ (ICD 10 code B.67.0–67.9); (b) 12 records (patients) were excluded
because the patients have not been operated on (4 surgery postponed, 3 post-surgical condition, 4 calcified cyst no
needing surgery, 1 no info), 11 because of missing surgical information, 20 records belonged to 15 patients who were
re-admitted once or twice; (c) 247 cases were analyzed.
https://doi.org/10.1371/journal.pntd.0006686.g001
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52.5% (95% CI 42–65), 25.8% (95% CI 15–30), 5.1% (95% CI 0–10) and 3.3% (95% CI 0.0–10),
respectively. 13.3% (95% CI 5–25) of the cysts were staged as CL in need for further diagnostic
work up (Fig 4).
Fig 2. Average CE surgical incidence in each province for the period 2008–2015. Abbreviations: BO-Bayan-Olgii,
UV-Uvs, HD-Khovd, ZA-Zavkhan, GA-Gobi-Altai, BH-Bayankhongor, OH-Ovorkhangai, AH- Arkhangai,
HG-Khubsgul, BU-Bulgan, DA-Darkhan, SE-Selenge, ER- Orkhon, UB-Ulaanbaatar, DU-Dundgobi, OG-Omnogobi,
TO- Tov, DG-Dornogobi, HN-Khentii, DD-Dornod, GS-Gobisumber., SB-Sukhbaatar.
https://doi.org/10.1371/journal.pntd.0006686.g002
Fig 3. Distribution of CE cyst stages on the basis of the WHO CE cyst classification. The average proportions (big
diamond) of CE cyst stages staged on the basis of the WHO CE cyst classification by the three experts. R1, R2, R3 are
the proportions (small diamonds) of CE cyst stages classified by the expert 1, 2, 3, respectively.
https://doi.org/10.1371/journal.pntd.0006686.g003
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Discussion
To the best of our knowledge this is the first description of the clinical management of CE
patients in a LICs / LMICs with an attempt to critically contrast current national practice with
WHO-IWGE expert consensus [20] on the basis of interrater agreement calculated from the
retrospective cyst staging by three independent experts. Mongolia offers the unique opportu-
nity for this exercise for two reasons. CE patients identified on the peripheral level of the health
care services are exclusively referred for confirmation and treatment to the three state hospitals
where patient records are carefully stored in archives with a discharge diagnosis on the front
page of each patient file. The data of 290 patients with the ‘discharge diagnosis CE’ (ICD 10
code B.67.0–67.9) admitted between 2008 and 2015 were available to characterize the CE
patients who currently receive treatment in Mongolia. Ultrasound photos of 46% (84/182) of
patients with abdominal cysts were available for retrospective cyst staging on the basis of
WHO CE cyst classification by three international experts. Based on the retrospective staging
result and size, proportions of assignment to WHO-IWGE recommended treatment modali-
ties were estimated.
The baseline data of the study population receiving treatment at the three state hospitals
show some interesting features. Around 50% of the patients are below 15 years of age. In
Kazakhstan and Kyrgyzstan, countries in the same region as Mongolia and have similar pasto-
ral lifestyle, also reported high proportion of children among the surgical cases [3]. Equal pro-
portions of male and female patients suggests that, understandably, the infection risk is equal
with CE transmitted in a food borne dog faecal-human oral cycle. Distance to the secondary
hospital is a relevant factor for access to specialized health care in all LICs and most MICs [32,
33]. About 40% of the surgical patients had to travel at least 100 km to reach the secondary
hospitals. Besides the geographic barrier other factors might contribute to underreporting but
currently no data are available. 80% of the patients are living in a “yurt” which suggest that
Fig 4. Assignment of CE cysts of the study population to WHO-IWGE recommended treatment modalities on the
basis of retrospective cyst staging by three international experts. In uncomplicated CE cysts WHO-IWGE
recommended assignment of patients to the four treatment modalities surgery, percutaneous methods, drug treatment
(albendazole, mebendazole) and watch & wait is based on cysts stage and size (three groups). A Three size groups and
the average percentages of WHO cysts stages in the study population as retrospectively staged by three international
reviewers. Although there was a small percentage (0.01%) of CE2 identified by the three reviewers (Fig 3) this stage
could not be included into the analysis because the information on cyst size was lacking. CE5 was excluded since none
of the reviewers attributed one of the cysts presented for retrospective staging to CE5. B Based on the matrix in A, the
probability of assignment of patients to the WHO-IWGE recommended treatment modalities is presented. The colors
of the cells in A and B matrices correspond to each other. Cysts staged as CL would have needed further diagnostic
work up.
https://doi.org/10.1371/journal.pntd.0006686.g004
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these patients are exposed to the combination of poor infrastructure, poor water and sanitation
and frequent contact with watch-dogs and their faeces [34, 35].
A significant proportion of patients presented with non-specific symptoms, around 20%
with abdominal pain which is 29% of those patients with abdominal cysts. Around 16.6%,
8.5% and 6.9% of all patients had cough, chest pain, dyspnoea, respectively. This amounts to
50%, 32%, and 14%, respectively, of patients with lung cyst. These results are in line with the
clinical experience that most patients present with non-specific symptoms and signs [36].
Fever, observed in 22.3% of all admissions may, however, indicate that some patients had com-
plication such as a cysto-biliary fistula with secondary bacterial infection of the cyst or cholan-
gitis associated with biliary obstruction due to spillage of cyst content into the biliary tree; the
latter also causes abdominal pain [37]. Similarly, patients with lung cysts may have fever due to
pneumonia following bronchial compression caused by expanding cysts or secondary bacterial
infection of the residual cavity after the cyst content has been expectorated via a cysto-bron-
chial fistula. Both complications are associated with cough and dyspnoea [38]. Care should be
exercised, however, to not over interpret retrospectively non-specific signs and symptoms
such as fever, documented in medical records.
Most patients had only a single cyst in abdominal organs of which almost 40% had a diame-
ter equal or smaller than 5 cm. This alone casts doubts on the indication for major surgery. If
uncomplicated, these cysts would—following the WHO-IWGE expert consensus—either fall
in the medical treatment group, if active (CE1 to CE3), or the watch & wait group, if inactive
(CE4 and 5).
Only 40 reports of the 182 abdominal cysts examined by ultrasound spelled out “hydatid
cyst” as the US diagnosis, without, however, mentioning accepted US criteria and without an
attempt to stage with the WHO-IWGE or Gharbi classification.
The most exciting part of this data set was the unique opportunity to review and retrospec-
tively stage 138 US imaging photos of 84 patients by three international experts to compare
current practice in Mongolia with WHO recommended treatment modalities [20]. The distri-
bution of WHO cyst stages retrospectively analysed from a subset of patients treated between
2008 and 2015 at the three state hospitals in Mongolia showed proportions of 0.59, 0.01, 0.19,
0.08, 0.03 and 0.11 for CE1, CE2, CE3a, CE3b, CE4, and CL, respectively (see Fig 3). Given the
relatively high number of categories, the observed raw agreement of about 80% and Kappa
coefficients of close to 0.6 indicate that the method appears to be generally valid but with room
for improvement. A similar result was found in a recent study assessing interrater agreement
of WHO cyst classification based on 2-D US images. The authors emphasized that an improve-
ment can be achieved when non-static imaging (video recording etc.) is incorporated in future
studies [39].
Assignment of patients to the WHO-IWGE recommended treatment modalities takes into
account cyst size in addition to cyst stage. Merging the cyst sizes with the retrospective WHO
cyst staging of the study population provides an insight into deviations of current practice in
Mongolia from the WHO-IWGE expert consensus. Of particular significance for patients
regarding unnecessary treatment risks and for the health care services with respect to avoidable
treatment costs is the fact that 3.3% of abdominal cysts would have not warranted any treat-
ment at all since they were already in an inactive stage (CE 4). Following WHO-IWGE expert
consensus they would have been submitted to the watch & wait approach with a very high
probability of no need for further treatment [28, 29]. 52.5% of active abdominal cysts (CE1
to CE3) with a diameter of 5 cm or smaller would have been submitted to medical treatment
following the WHO-IWGE expert consensus [20, 40]. This draws attention to the fact that
availability of albendzole, the preferred benzimidazole for CE therapy, is hugely lacking in
Mongolia. Currently, the price of albendazole is very high with approximately US$2 per
Clinical management of cystic echinococcosis in Mongolia
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400mg tablet. Albendazole is mostly sold in pharmacies in cities, which also limits access.
Access to albendazole is a very much debated issue in the care for the neglected tropical disease
echinococcosis in neglected populations [41]. In addition to albendazole cost, 10–15% of the
hospital admission fee of public hospital is paid by the patients and the remaining cost is cov-
ered from the national health system in Mongolia [42]. However, there are many other costs
including, informal fees to clinicians and advanced diagnostics increasing the economic bur-
den CE patients have to carry. Almost 26% of the patients assessed would have been allocated
to percutaneous treatment (PT). PT options are generally underused and are not carried out in
Mongolia for CE management due to a lack of trained personnel. Introducing PT into Mongo-
lia should be considered because of its advantages of carrying less risks for the patients and
reduction of treatment cost and length of hospital stay. A study in Bulgaria showed similar
deviations from best practices as recommended by WHO-IWGE expert consensus[43].
There are several limitations of the study. The data were extracted retrospectively from
patient files. The fact that in Mongolia CE patients are being treated exclusively at the three
national hospitals with high standards of documentation and archiving compensated partly
for this shortcoming. Also cyst staging was retrospectively performed on the basis of 2-D ultra-
sound photos. Our inter-rater agreement of retrospective cyst staging, however, gives confi-
dence that the staging result provides an acceptable estimate of the distribution of cyst stages
seen at the three national hospitals. Identifying complicated cysts is difficult in retrospective
studies. In some instances we could suspect that a cyst was complicated by combining various
pieces of available retrospective information (eg fever, abdominal pain plus US cyst features
suspicious of secondary bacterial infection of a cyst). This, however, is all too vague and would
be an over interpretation of retrospective data. We thus did the analysis “as if” the cysts of the
US images classified were uncomplicated. This may have resulted in an overestimate of the
non-surgical treatment modalities.
In conclusion, our study demonstrates
1. Mongolia has a significant section of the population suffering from cystic echinococcosis
and in need of implementing a LMIC-adapted version of the WHO-IWGE expert
consensus
2. Access to the privileged treatment centres, the three state hospitals, may be limited by geo-
graphic distance and economic resources
3. Ultrasonography is available, but diagnostic CE criteria seem not to be sufficiently well
known and cyst staging is not performed
4. WHO-IWGE expert consensus for assigning patients to the four treatment options based
on CE cyst staging and cyst size are not implemented resulting in surgical treatment of all
CE patients and in an unnecessary high risk approach in patients who could be treated with
albendazole or percutaneously or observed (watch & wait).
It is recommended
1. To systematically include CE into the disease surveillance system of Mongolia
2. To make ultrasonography available to the primary / secondary health care level and to train
local, physicians in the diagnostic features of WHO CE cyst staging. The Focused Assess-
ment with Sonography for Echinococcosis (FASE), a short term course for general practi-
tioners, could be a model [26]. In 2016, a pilot training was conducted on WHO-CE cyst
classification and staging for primary/secondary ultrasonography doctors by leading
experts in the field.
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3. To introduce and implement the WHO-IWGE expert consensus at all levels of the health
care system to triage patients into the four WHO treatment modalities (a) medical treat-
ment of small active cysts, (b) percutaneous treatment of larger active cysts (CE 1 and CE
3a), (c) surgery for complicated, very large cysts and cysts unresponsive to medical therapy,
and (d) watch & wait for inactive cysts (CE4 and 5). Implementation at the primary and sec-
ondary health care levels saves transport costs, travel time for patients and allows a substan-
tial proportion of patients to stay near or in their homes during treatment.
4. To apply our strategy of assessing CE clinical epidemiology and management in other CE
endemic LICs / LMICs as a basis for planning
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